Alemtuzumab treatment in Multiple Sclerosis: real clinical experience in the Northwest of Spain

被引：0

作者：

Lopez Real, Ana ^{[1
]}

Gonzalez Suarez, Ines ^{[2
]}

Costa Arpin, Eva ^{[3
]}

Pato Pato, Antonio ^{[4
]}

Alvarez Rodriguez, Elena ^{[2
]}

Rodriguez Regal, Ana ^{[5
]}

Garcia-Pelayo Rodriguez, Ana ^{[1
]}

Garcia Bargo, Maria Dolores ^{[6
]}

Llaneza Gonzalez, Miguel ^{[7
]}

Rodriguez Rodriguez, Maria ^{[8
]}

Solar Sanchez, Dulce Maria ^{[9
]}

Oterino Duran, Agustin ^{[10
]}

Pena Martinez, Joaquin ^{[11
]}

机构：

[1] Univ Hosp A Coruna, Neurol, La Coruna, Spain

[2] Univ Hosp Vigo, Neurol, Vigo, Spain

[3] Univ Hosp Santiago De Compostela, Neurol, Santiago De Compostela, Spain

[4] Povisa Hosp Vigo, Neurol, Vigo, Spain

[5] Univ Hosp Pontevedra, Neurol, Pontevedra, Spain

[6] Univ Hosp Ourense, Neurol, Orense, Spain

[7] Univ Hosp Ferrol, Neurol, Ferrol, Spain

[8] Hosp Lucus Augusti, Lugo, Spain

[9] Univ Hosp Cabuenes, Neurol, Gijon, Spain

[10] Univ Hosp Marques Valdecilla, Neurol, Santander, Spain

[11] Univ Hosp San Agustin, Neurol, Aviles, Spain

来源：

NEUROLOGY | 2018年 / 90卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P6.352

引用

页数：3

共 50 条

[41] Alemtuzumab for Multiple Sclerosis
Willis, Mark D.
Robertson, Neil P.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (09)
[42] Clinical experience with rituximab in the treatment of refractory multiple sclerosis
Gascon, F.
Navarre, A.
Alcala, C.
Lacruz, L.
Perez-Miralles, F.
Bosca, I.
Casanova, B.
Coret, F.
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 207 - 208
[43] Autoimmune Hepatitis During Treatment of Multiple Sclerosis with Alemtuzumab
Carlson, Aaron
Bozinov, Nina
Kipp, Lucas
Dunn, Jeffrey
Lock, Christopher
NEUROLOGY, 2018, 90
[44] Magnetisation transfer imaging of alemtuzumab treatment of multiple sclerosis
Button, T.
Altmann, D.
Tozer, D.
Dalton, C.
Compston, D. A. S.
Miller, D.
Coles, A. J.
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S437 - S437
[45] Alemtuzumab Immunotherapy of Treatment-Refractory Multiple Sclerosis
Hunter, Samuel F.
Hunter, Heli M.
Brown, Janet M.
Eby, Leiah C.
NEUROLOGY, 2009, 72 (11) : A359 - A359
[46] HYPERSENSITIVITY PNEUMONITIS FOLLOWING ALEMTUZUMAB TREATMENT FOR MULTIPLE SCLEROSIS
Willis, Mark
Cossburn, Mark
Ingram, Gillian
Pickersgill, Trevor
Barry, Simon
Robertson, Neil
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
[47] One Year Alemtuzumab - What have we Learned in Clinical Practice? Exchange of Experience between Experts on Treatment of Multiple Sclerosis
Bayas, A.
Baum, K.
Bitsch, A.
Haas, J.
Hellwig, K.
Lang, M.
Lee, D. -H.
Rosenkranz, T.
Schreiber, M.
Ulzheimer, J. C.
Ziemssen, T.
AKTUELLE NEUROLOGIE, 2015, 42 (09) : 535 - 541
[48] Acquired haemophilia A after alemtuzumab treatment of multiple sclerosis
Brink, Huguette S.
Moll, Wibe
Sandberg, Yorick
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (01) : 13 - 13
[49] Immune competence after alemtuzumab treatment of multiple sclerosis
McCarthy, Claire L.
Tuohy, Orla
Compston, D. Alastair S.
Kumararatne, Dinakantha S.
Coles, Alasdair J.
Jones, Joanne L.
NEUROLOGY, 2013, 81 (10) : 872 - 876
[50] Results of treatment with alemtuzumab in a Spanish cohort of patients with multiple sclerosis in the real world: The RealMS study
Eichau, Sara
Ruiz, Rocio Lopez
de Arcos, Maria Ruiz
Ruiz-Pena, Juan Luis
Navarro, Guillermo
Calleja, Miguel Angel
Moreno-Amador, Jose Luis
Garcia-Soto, Julio Dotor
FRONTIERS IN NEUROLOGY, 2023, 14

← 1 2 3 4 5 →